{"id":"W4405128969","doi":"10.1038/s41391-024-00924-x","title":"Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparison","year":2024,"lang":"en","type":"article","venue":"Prostate Cancer and Prostatic Diseases","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"Pfizer","keywords":"Abiraterone acetate; Medicine; Enzalutamide; Olaparib; Prostate cancer; Oncology; Internal medicine; Confidence interval; Hazard ratio; Urology; Cancer; Androgen deprivation therapy; Poly ADP ribose polymerase; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005359843,0.00169827,0.003115701,0.0007732442,0.0001987301,0.0008378006,0.001293792,0.001026392,0.007597291],"category_scores_gemma":[0.007504061,0.0005265042,0.006637782,0.0005501332,0.0005817306,0.0007500066,0.001115841,0.001896778,0.00050801],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00099401,"about_ca_system_score_gemma":0.000825798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001092605,"about_ca_topic_score_gemma":0.001527174,"domain_scores_codex":[0.9929008,0.005389817,0.0003823799,0.0005787339,0.0004199732,0.0003282833],"domain_scores_gemma":[0.9964317,0.002045583,0.0008443626,0.0003038766,0.0001447525,0.0002296833],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.9355581,0.001321551,0.0050428,0.002241804,0.02810552,0.00005458852,0.00009220201,0.003217579,0.00131197,0.0006564393,0.0006495422,0.02174782],"study_design_scores_gemma":[0.5681544,0.2669417,0.04638412,0.0006076145,0.08482718,0.0003078369,0.0002389417,0.01707591,0.003995041,0.004245417,0.00705897,0.0001628823],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9743648,0.01080628,0.003993053,0.0003647018,0.0006949544,0.002610278,0.002711024,0.0001065369,0.004348497],"genre_scores_gemma":[0.991855,0.001129341,0.002260679,0.0002414412,0.0001482246,0.001831488,0.0008416579,0.00001686043,0.001675189],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007597291,"threshold_uncertainty_score":0.02834588,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06014608473707125,"score_gpt":0.3616965064831839,"score_spread":0.3015504217461127,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}